Abstract:Background Turner's syndrome (TS) is the most common genetic abnormality affecting females and is characterised by complete or partial absence of the X chromosome. Mortality is predominantly related to cardiovascular disease (1). Risk of life-threatening aortic dissection is 40 per 100,000 (2). Indexed aorta size (ASI) to body surface area (BSA) >20mm/m2 is considered abnormal. An ASI of ≥25mm/m2 is associated with increased risk of aortic dissection (3). Despite this there is a paucity of data in the literature regarding TS cardiovascular disease and providing evidence-based care can be challenging. Purpose Define cardiovascular disease, with focus upon aortopathy in our TS Cardiovascular Clinic (TCC). Methods Single centre retrospective medical record analysis of 248 women with TS (2021-2024) Results Patient baseline characteristics; mean age 37 years (range 18-75yrs), height 150cm (132-169cm), weight 62kg (37-130kg), BSA 1.55m2 (1.19-2.17m2). 65 patients (29%) had bicuspid aortic valve (BAV), 19 (8%) and 5 (3%) had repaired and un-repaired aortic coarctation (CoA) respectively. 30 (13%) had other congenital heart disease, with most common was partial anomalous pulmonary venous connection (12 patients: 5%). 22/248 patients had previous aortic root surgery; 20 elective (mean ASI 29mm/m2, range 26-33mm/m2, mean age at time of surgery 42 years); 2 presented with aortic dissection (ASI 21mm/m2; pregnant, BAV & 24mm/m2; tri-leaflet aortic valve, TAV). Data was available for 221 unoperated patients (figure 1). The site of maximal dimension was observed at the sinus of Valsalva in 70% compared to 30% at the ascending aorta. 130 patients (59%) had maximal ASI of 25mm/m2. 4 patients (2%) had an absolute maximal dimension of 40mm with ASI of 23mm/m2 for all four. 9/11 patients with dimension ≥25mm/m2 or 40mm had a body mass index (BMI) >25kg/m2. Review of medical history for patients at and above threshold for risk of aortic dissection revealed referral to or previous discussion in an Aortic multi-disciplinary meeting (MDT) with a plan for ongoing surveillance. 57 patients (35%) with TAV had significant aortopathy (mean age 46years, range 19-75years) compared with 33 (51%) with BAV (mean age 39yrs, range 22-72 years) (figure 2). Review of patients >55years of age demonstrated a very similar burden of aortopathy in both TAV (14%) and BAV (15%) populations. Conclusions A high burden of cardiovascular disease exists within our TS population. There is a very high prevalence of aortopathy, increasingly with age and both with and without the presence of a bicuspid aortic valve. More published data is needed to help better define those at risk.

Turner syndrome and aortic complications: more benign than previously thought

Cardiovascular health in women with turner's syndrome: a 3-year single centre audit

Severe aortic regurgitation and partial anomalous pulmonary venous connection in a Turner syndrome patient.

Cardiovascular Manifestations of Turner Syndrome: Phenotypic Differences Between Karyotype Subtypes

Exon 47 Skipping of Fibrillin-1 Leads Preferentially to Cardiovascular Defects in Patients with Thoracic Aortic Aneurysms and Dissections

Working towards risk stratification for ascending aortic dilatation in pediatric Turner syndrome patients: results of a longitudinal echocardiographical observation

Cardiovascular health in turner syndrome: Manifestations, endocrine, and metabolic risk factors with a look at clinical practice

Risk assessment for aortic dissection in Turner syndrome: The role of the aortic growth rate

Turner Syndrome where are we?

Partial anomalous pulmonary venous connection and pulmonary venous varix coexist in Turner syndrome: a case report

Aortic tortuosity in Turner syndrome is associated with larger ascending aorta

Organ Abnormalities Caused by Turner Syndrome

Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension

Cardiovascular Disease and Inpatient Complications in Turner Syndrome: A Propensity Score Analysis

Evaluation of cardiovascular disease in the turner syndrome population in Northern Ireland

A Diagnosis of Turner Syndrome in the Eighth Decade of Life

Maternal cardiovascular morbidity and mortality associated with pregnancy in individuals with Turner syndrome: a committee opinion

Bullous Lung Disease in Turner Syndrome: An Underrecognized Comorbidity?

Chromosomal Abnormalities of Interest in Turner Syndrome: An Update

Massive Pericardial Effusion and Cardiac Tamponade Revealed Undiagnosed Turner Syndrome: a Case Report

Hidden Y Chromosome Material and Congenital Cardiovascular Malformations in a Cohort of Turner Syndrome Patients with 45,X Blood Karyotype